
Seeing a 25-year-old who made it to a Grand Slam semifinal just two years ago return to a tennis court with a noticeably different appearance and win a title is almost disorienting. That’s what Emma Navarro did in Strasbourg in May 2026, and to be honest, there was a pretty noticeable discrepancy between what the public had been saying about her and what she actually did on that clay court.
Early in 2026, the discussion surrounding Navarro quickly became uncomfortable. Online tennis conversations centered on a noticeable shift in Navarro’s body during her comeback to competition, with fans and social media users pointing out what seemed to be substantial weight gain during multiple tournament appearances. Forums were teeming with conjecture. It was sympathetic to some extent. Most of it wasn’t. It’s difficult not to find it depressing, even if it’s not totally surprising, that comments about bodies, fitness, and what the female athlete must or must not be doing have begun to appear regularly.
According to what Navarro and those close to her have since disclosed, what was actually taking place was far less scandalous. In March 2026, she was compelled to withdraw from her home tournament, the Credit One Charleston Open. In an emotional statement, she revealed that she had been struggling with her health for the previous year or so. Her team members identified hypothyroidism—an underfunctioning thyroid gland that interferes with metabolism and can lead to fatigue, weight fluctuations, and a general feeling that the body isn’t reacting as it should—as a major concern. Many supporters pointed out that her changed appearance was probably caused by medication, especially corticosteroids, which are known to cause significant side effects like puffiness and water retention.
It’s worth taking a moment to consider that. The woman being scrutinized on forums for her appearance was likely gaining weight specifically to treat a medical condition. Under normal circumstances, the tour is cruel to bodies. The notion that Navarro should have looked the same as she did during her breakout 2024 season becomes nearly ludicrous when you include a thyroid condition and a course of corticosteroids. She wouldn’t be the first famous tennis player to struggle with an autoimmune condition; Caroline Wozniacki battled rheumatoid arthritis for years, and Venus Williams managed Sjogren’s syndrome. Nevertheless, that was the standard expectation that was being used.
Navarro herself gave a straightforward account of the experience, saying that the tour is difficult and will exhaust you due to the constant travel and physical and mental strain, which exacerbates any internal issues already present. At one point, she completely left the circuit, avoiding matches and scores to feel like a regular person once more. She was surrounded by family and medical professionals during this time of rest, which eventually turned out to be the cornerstone of her comeback.
Knowing when to stop has its advantages. With a top 40 ranking in 2023, a first WTA title in early 2024, a US Open semifinal that same year, and a world No. 8 ranking by September, Navarro’s career had advanced at a rate that left little time for pause. Recovery time is not a natural part of that trajectory. The body might have just submitted a formal complaint.
When Navarro returned to the tour in Strasbourg, she dominated rather than just played. In terms of both the field she defeated and the circumstances surrounding her return, she won the WTA 500 title, her biggest trophy to date, by storming through the draw. The timing had an almost pointed quality. When she emerged victorious in a three-set clay-court championship match against top seed Victoria Mboko, the remarks had hardly subsided. A few days prior, she had won her 100th match on the WTA Tour in the same city. That was not what the illness had taken from her in the months before.
Given the amount of ground she had to cover, her description of herself as a work in progress but one who had made significant progress feels like a major understatement. It’s difficult not to think that the weight gain that everyone was talking about in 2026 isn’t the most revealing aspect of Emma Navarro’s story as you watch this specific arc unfold. It’s all that was going on underneath it, silently, as the commentary continued.
